Phase I Study Of Bpm31510 And Vitamin K In Patients With High Grade Glioma Recurrent After A Bevacizumab-Containing Regimen.
JOURNAL OF CLINICAL ONCOLOGY(2020)
摘要
2543Background: BPM31510 is an ubidecarenone-lipid conjugate nanodispersion in clinical development for advanced malignancies, including high grade glioma (HGG). BPM31510’s anti-cancer effect is me...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络